Latest News and Press Releases

YONKERS, NY--(Marketwired - Oct 1, 2013) - ContraFect Corporation announced that Dr. Robert Nowinski, the company's founder and chief executive officer, and Julia P. Gregory, the company's...

YONKERS, NY--(Marketwired - Sep 5, 2013) -  ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Robert C. Nowinski, the Company's...

YONKERS, NY--(Marketwired - Sep 4, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, is pleased to announce that it has successfully closed a...

YONKERS, NY--(Marketwired - Aug 22, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, is pleased to announce that ContraFect has been selected to...

YONKERS, NY--(Marketwire - Jan 4, 2013) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Robert Nowinski, the Company's founder...

YONKERS, NY--(Marketwire - Oct 3, 2012) - ContraFect Corporation, developing biotherapeutics for life-threatening infectious diseases, today announced that Julia P. Gregory, the Company's executive...

YONKERS, NY--(Marketwire - Sep 12, 2012) - ContraFect Corporation announced today that it has expanded the senior management of the company with the addition of biotechnology veteran Julia Gregory...

YONKERS, NY--(Marketwire - Jun 26, 2012) - ContraFect Corporation announced today that Sir Richard Sykes, FRS, has joined the company's Board of Directors. Sir Richard has over 30 years of...

YONKERS, NY--(Marketwire - Mar 8, 2012) - ContraFect Corporation announced today that Sol Barer, Ph.D. has been named the company's Chairman of the Board. Dr. Barer has been a director of...

YONKERS, NY--(Marketwire - Dec 14, 2011) - ContraFect Corporation, the company that is pioneering the use of recombinant proteins for the treatment of drug-resistant bacteria, completed a...